Genmab — August 2017
-
En gammel nyhed fra Genmabs hjemmeside; The DuoBody technology is an easy-to-use method for the generation of therapeutic human IgG1 bispecific antibodies (bsAb). To facilitate the investigation of dual-targeting concepts in immuno-competent mice, we now applied and optimized our technology for the generation of murine bsAbs.http://www.genmab.com/duobody/news/murine-bispecific-antibodies
-
God morgen.
-
Så sker der da lidt i senatet. Troede de var blevet handlingslammede. http://www.fiercebiotech.com/biotech/senate-passes-fda-user-fee-and-right-to-try-bills?utm_medium=nl&utm_source=internal&mrkid=41140432&mkt_tok=eyJpIjoiTlRCak1tRTFZV0U1WTJJeSIsInQiOiJNazNaTDRTUmNpSTlFeldMZ281cXNXV3pNTDBYSGFvbmZSUk9aeUJIOVVVQ1l4MUJ6djJhaVRuY2Rtd3FMUEFwUHBtZFFieXArWGlPM1gxT1BsYTZwSHQ0c203Q0luRU9hTHRBWEZwSUJDXC9rbWVMRnJWRFZVTjlVdW1yMHNqV0gifQ%3D%3D
-
God aften till alle. Er der nogen af eksperterne i gruppen, som har nogen forventninger til halv-årsregnskabet?
-
God morgen. Jeg ville ikke have noget imod en udskiftning i bestyrelsen. Jeg kan ikke se hvad Pernille Erenbjerg bidrager med i Genmab bestyrelsen: http://itwatch.dk/ITNyt/Brancher/tele/article9768671.ece
-
God morgen.
-
Meget gerne spørgsmål til Q&A allerede i dag.
-
jkj mange for dit svar. Men baseret på de rapporterede salgstal i USD, vil dette ikke medføre et øget target til årets omsætning i USD?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind